Through a siRNA-mediate inhibition approach, the depletion of OLR1 suppresses growth of MCF7 (breast cancer), HepG2 (hepatocellular carcinoma) and HeLa (cervical cancer) cells while affecting the growth of non-transformed cell lines. The gene discussed is OLR1; the disease is cervical cancer.